GC Therapeutics is based in Cambridge, Massachusetts. It has raised $75M in total funding. Latest round: Series A.
GC Therapeutics is based in Cambridge, Massachusetts. GC Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for GC Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Mubadala Capital, a16z Bio + Health, Medical Excellence Capital, Cercano Management, Pear VC and 1 others. 7 distinct backers are named across the disclosed rounds.
Round data for GC Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026